您的位置: 首页 > 农业专利 > 详情页

GLUCOCORTICOID RECEPTOR AGONIST COMPRISING NOVEL 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE CONTAINING PHENYL GROUP HAVING SULFONIC ACID ESTER INTRODUCED THEREIN AS SUBSTITUENT
专利权人:
SANTEN PHARMACEUTICAL CO.; LTD
发明人:
KATO, MASATOMO,TAKAI, MIWA,MATSUYAMA, TAKAHIRO,KUROSE, TATSUJI,HAGIWARA, YUMI,OKI, KENJI,MATSUDA, MAMORU,MORI, TOSHIYUKI
申请号:
GEAP2009012178
公开号:
GEP20135804B
申请日:
2009.09.11
申请国别(地区):
GE
年份:
2013
代理人:
摘要:
The invention relates to 1,2,3,4-tetrahydroquinoxaline novel derivatives of common formula (1), containing a phenyl group as a substituent. The phenyl group includes sulfonic acid ester. The invention also relates to their application as glucocorticoid receptor agonist, particularly for bone-joint and ophthalmic inflammatory diseases treatment.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充